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Abstract
Aim To evaluate the CVC-related infection rate according to catheter insertion site and to analyze the risk factors
for catheter-related local infections (CRLI) and bloodstream infections (CRBSI) among severe trauma patients.
Methods We reviewed the medical records of 736 severe trauma patients with an Injury Severity Score of[15.
Poisson regression was used to compare the infection rates according to the catheter insertion sites. Univariate
analysis of the groups with and without CVC-related infection was used to identify confounding variables for
inclusion in multivariate models that were used to identify the risk factors for CRLI and CRBSI.
Results We evaluated 1646 catheter insertions and their duration of insertion and found 1241 subclavian
(18,461 days), 251 internal jugular (3454 days), and 154 femoral catheters (1526 days). The CRLI infection rate per
1000 catheter days was significantly lower for subclavian, compared to that for internal jugular (4.83 vs. 9.55,
respectively; P\ 0.001) and femoral catheters (4.83 vs. 7.93, respectively; P = 0.013). Multivariate logistic
regression analysis revealed that catheter insertion duration [odds ratio (95 % confidence interval): 1.035
(1.021–1.050), P\ 0.001] and subclavian access [0.532 (0.366–0.775), P\ 0.001] were significantly associated
with CRLI, while catheter insertion duration [1.024 (1.002–1.046), P = 0.032] was significantly associated with
CRBSI.
Conclusions To reduce the rate of CVC-related infections in severe trauma patients, we suggest that catheters be
shifted from the internal jugular or femoral veins to the subclavian vein as soon as possible and that the duration of
catheter insertion should be minimized.
Introduction
Central venous catheters (CVCs) are inserted for severe
trauma patients who are hemodynamically unstable at the
time of their admission to the trauma department. Other
indications for CVCs include resuscitations and patients
with a deteriorating condition after surgical or radiological
interventions. In this context, CVCs provide many benefits
in the acute and critical care fields, including hemodynamic
monitoring, fluid resuscitation, massive transfusion,
administration of medication, and nutritional support [1, 2].
However, despite these benefits, CVCs are associated with
various complications, including infections, hemorrhage,
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pneumothorax, arterial puncture, and thrombosis. Among
these complications, CVC-related infections are the most
studied, as they can significantly influence the length of
intensive care unit (ICU) stays, hospital costs, and mor-
tality rates (up to 25 %) [3–6]. Various studies of CVC-
related infections in the critical care setting have been
reported, and various treatment guidelines have been
developed based on their findings, including the Centers for
Disease Control’s (CDC) guidelines. However, while many
studies have evaluated CVC-related infections in critically
ill patients, few studies have evaluated these infections in
severe trauma patients. Therefore, this study aimed to
evaluate infection rate according to catheter insertion site
and to analyze the risk factors for CVC-related infection
among severe trauma patients.
Materials and methods
This observational study was conducted at Ajou University
Hospital (Suwon, Korea), which is a leading tertiary hos-
pital in Korea, with an annual emergency department
volume of 16,000 trauma patients, many of whom have an
ISS of[15. Most polytrauma patients, except those with
isolated brain or solitary orthopedic injuries, are admitted
to the Division of Trauma Surgery. Between January 2009
and December 2013, 1178 patients were admitted to our
department via the emergency room, including 736 patients
who had an ISS of[15. Among these 736 patients, 698
patients received CVCs, including 56 patients who subse-
quently died. However, we did not censor their data,
because we inspected the insertion site at every dressing
time, even on the day of death. In contrast, we excluded all
cases involving peripherally inserted central catheters, as
their insertions were away from the three sites of interest.
This study’s design was reviewed and approved by the
institutional review board of Ajou University Hospital
(IRB No. MED-OBS-14-402).
The most common indications for CVC insertion were
hemodynamic instability due to trauma and total parenteral
nutrition after admission. The primary access site was the
subclavian vein, with the internal jugular and femoral veins
serving as secondary access sites, although the physician
who inserted the catheter made the final decision at the
time of the insertion. However, given the general features
of trauma patients, it was not always possible to use the
primary access site, based on nearby injuries.
Maximum full barrier protection was used whenever
possible, although these protocols occasionally could not
be followed in cases that required urgent care. The CVCs
that were inserted during urgent care were removed within
72 h (as soon as possible). All catheters were coated in
antibiotics, and ultrasonography was occasionally used to
guide the insertion, based on the physicians’ discretion.
After insertion, a disposable sterile gauze dressing or
transparent dressing was applied, although no antibiotic
cream or lotion was applied around the insertion site.
While the catheter was maintained, the line connections
were strictly controlled to avoid contamination, and strict
hand hygiene was observed before and after catheter
manipulation. We removed the catheter when the indica-
tion for the insertion had resolved, or when signs of local
infection were observed when changing the dressing. In the
present study, fever with an unknown cause or an insertion
duration of [2 weeks were considered indications for
removal, even in the absence of other infection signs. In
addition, based on previous studies, femoral catheters were
immediately moved to the subclavian (first priority) or
internal jugular (second priority) veins when those sites
became accessible, even if there were no signs of infection.
We reviewed the patients’ general information from
their medical charts, including sex, age, ISS, length of ICU
stay, duration of catheter insertion, catheter insertion sites,
catheter types, reasons for catheter removal, CVC-related
infection, and related microorganism. Catheter types were
classified as single-lumen, double-lumen, and triple-lumen
catheters according to the number of lumens. Single-lumen
catheters included the ARROW CVC (Arrow, Reading,
PA, USA) and the IntroFlexTM (Edwards Lifesciences,
Irvine, CA, USA); double-lumen catheters included the
ARROW CVC, the ARROW MAC, and the MAHUR-
KARTM (11.5-Fr dual-lumen catheters for acute dialysis;
Covidien, Mansfield, MA, USA); and the triple-lumen
catheters were the ARROW CVCs. CVC-related infec-
tions were divided into catheter-related local infections
(CRLI) and bloodstream infections (CRBSI). We defined
CRLI as local signs of infection at the insertion site,
including erythema, local pain, inflammation, or purulent
discharge, with microorganism colonization of the catheter
tip. CRBSI was defined as the presence of signs of systemic
infection with positive culture results from the peripheral
venous blood and catheter tip. We diagnosed CRBSI based
on the presence of[15 colony-forming units in the catheter
tip culture and after excluding other non-catheter sources
of infection.
SPSS software (version 21.0, IBM Corp, Armonk, NY)
was used for all statistical analyses. Poisson regression
distribution with general log-linear analysis was used to
compare the infection rates and determine the risk of
infection according to the catheter insertion sites. Variables
were reported as median (range) or number (percentage),
and the v2, Fisher’s exact, or Mann–Whitney U test was
used, as appropriate. To identify the variables confounding
the risk factors for catheter-related infection, univariate
analysis was used to compare the groups with and without
infection. Multivariate modeling was performed using
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conditional logistic regression with a backward stepwise
elimination procedure, and variables were selected for
inclusion in the model based on the results of the univariate
analysis (P value\0.1). For all other tests, a P value of
\0.05 was used to determine statistical significance.
Results
Among the 736 (62.5 %) severe trauma patients with an
ISS of [15, 556 patients (75.5 %) were men and the
median age was 48 (3–94) years. The median ISS was 22
(16–75) and the median length of the ICU stay was 11
(0–190) days. A total of 1646 CVCs were inserted into the
subclavian (n = 1241), internal jugular (n = 251), and
femoral (n = 154) veins. The total duration for subclavian
catheters was 18,461 days (median, 13 days; range
1–99 days), compared to 3454 days (12; 1–63) for internal
jugular catheters and 1526 days (5; 1–52) for femoral
catheters (Table 1).
We observed 139 cases of CRLI and 58 cases of
CRBSI, with rates of 5.75 and 2.44 per 1000 days,
respectively. The subclavian vein was involved in 91
CRLI episodes (4.83 per 1000 days), compared to 33
episodes (9.55 per 1000 days) in the internal jugular vein
and 15 episodes (7.93 per 1000 days) in the femoral vein.
The subclavian vein had a significantly lower CRLI rate,
compared to the internal jugular and femoral veins [odds
ratio (OR) 0.516, 95 % confidence interval (CI)
0.346–0.768, P = 0.001, and OR 0.501, 95 % CI
0.290–0.866, P = 0.013, respectively]. However, the
internal jugular and femoral veins did not exhibit a sig-
nificant difference in their CRLI rate (OR 0.972, 95 % CI
0.528–1.789, P = 0.927) (Table 2). The subclavian vein
was involved in 43 CRBSI episodes (2.28 per 1000 days),
compared to 12 episodes (3.47 per 1000 days) in the
internal jugular and three episodes (0.61 per 1000 days)
in the femoral veins. However, these differences were not
significantly different when we compared the subclavian
and internal jugular (OR 0.670, 95 % CI 0.354–1.271,
P = 0.221), the subclavian and femoral (OR 1.185, 95 %
CI 0.368–3.819, P = 0.776), or the internal jugular and
femoral veins (OR 1.767, 95 % CI 0.499–6.262,
P = 0.378) (Table 3).
Table 1 Catheter-related infections according to the insertion site
Insertion site Number of
catheters











Subclavian 1241 18,461 13 (7–21) 91 (7.33) 4.83 43 (3.46) 2.28
Internal jugular 251 3454 12 (6–20) 33 (13.15) 9.55 12 (4.78) 3.47
Femoral 154 1526 5 (3–15) 15 (9.74) 7.93 3 (1.96) 0.61
Total 1646 23,441 12 (6–20) 139 (8.44) 5.75 58 (3.52) 2.44
CRLI catheter-related local infection, CRBSI catheter-related bloodstream infection, IQR interquartile range, CVC central venous catheter
Table 2 Comparison of central venous catheter-related local infections according to the insertion site
Insertion site Number of infections per 1000 catheter days OR (95 % CI) P value
Subclavian versus internal jugular 4.83 vs. 9.55 0.516 (0.346–0.768) 0.001
Subclavian versus femoral 4.83 vs. 7.93 0.501 (0.290–0.866) 0.013
Internal jugular versus femoral 9.55 vs. 7.93 0.972 (0.528–1.789) 0.927
OR odds ratio, CI confidence interval
Table 3 Comparison of central venous catheter-related bloodstream infections according to the insertion site
Insertion site Number of infections per 1000 catheter days OR (95 % CI) P value
Subclavian versus internal jugular 2.28 vs. 3.47 0.670 (0.354–1.271) 0.221
Subclavian versus femoral 2.28 vs. 0.61 1.185 (0.368–3.819) 0.776
Internal jugular versus femoral 3.47 vs. 0.61 1.767 (0.499–6.262) 0.378
OR odds ratio, CI confidence interval
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When we evaluated the CRBSI cases, we observed 58
causative microorganisms, including 32 gram-positive
bacteria, 10 gram-negative bacteria, and 17 yeast strains.
Coagulase-negative Staphylococci were involved in 21
cases, Staphylococcus aureus was involved in 9 cases,
Acinetobacter baumannii in 5 cases, Enterococcus faecalis
in 2 cases, Serratia marcescens in 2 cases, and Klebsiella
pneumonia in 2 cases; no cases were involved Pseu-
domonas infection. Among the yeast infections, Candida
parapsilosis was involved in 9 cases, Candida albicans in 6
cases, and Candida pelliculosa and Candida intermedia in
1 case each (Table 4).
In the univariate analysis, length of ICU stay, catheter
insertion duration, catheter insertion site (subclavian), and
total parenteral nutrition (TPN) administration were asso-
ciated with CRLI (P\ 0.1) (Table 5). Although TPN
administration was found to be a significant factor, it was
not included in multivariate analysis because the MAC and
MAHUKAR catheters (which comprised a large portion of
the CVCs) cannot accommodate TPN administration.
Multivariate analysis revealed that catheter insertion
duration (OR 1.035, 95 % CI 1.021–1.050, P\ 0.001) and
subclavian access (OR 0.532, 95 % CI 0.366–0.775,
P\ 0.001) were significantly associated with CRLI
(Table 6). Similar analysis for CRBSI identified length of
ICU stay, catheter insertion duration, and number of
catheter lumens as potential associated factors, although
only catheter insertion duration (OR 1.024, 95 % CI
Table 4 Microorganisms responsible for central venous catheter-re-
lated bloodstream infections
Microorganism Number Percent (%)
Gram positive 32 55.2
Coagulase-negative Staphylococci 21 36.2
Staphylococcus aureus 9 15.5
Enterococcus faecalis 2 3.4
Gram negative 9 15.5
Acinetobacter baumannii 5 8.6
Serratia marcescens 2 3.4
Klebsiella pneumonia 2 3.4
Yeast 17 29.3
Candida parapsilosis 9 15.5
Candida albicans 6 10.3
Candida pelliculosa 1 1.7
Candida intermedia 1 1.7
Total 58 100.0










Age (years) 52 (3–94) 51 (8–86) 0.657 51 (16–84) 51 (3–94) 0.541
Sex, % male 79.9 % (111) 77.2 % (1163) 0.469 81.0 % (47) 77.3 % (1227) 0.500
ICU length of stay (days) 35 (0–148) 21 (0–190) \0.001 32 (4–148) 22 (0–190) 0.033
Catheter insertion duration (days) 16 (1–53) 11 (1–99) \0.001 17.5 (5–37) 12 (1–99) \0.001
Injury Severity Score 25 (16–50) 25 (16–75) 0.953 25 (16–50) 25 (16–75) 0.730
Catheter insertion sites 0.009 0.316
Subclavian 65.5 % (91) 76.3 % (1,150) 74.1 % (43) 75.4 % (1198)
Internal jugular 23.7 % (33) 14.5 % (218) 20.7 % (12) 15.1 % (239)
Femoral 10.8 % (15) 9.2 % (139) 5.2 % (3) 9.5 % (151)
Catheter typea 0.266 0.036
Single-lumen 4.3 % (6) 5.8 % (87) 1.7 % (1) 5.8 % (92)
Double-lumen 34.5 % (48) 40.1 % (605) 27.6 % (16) 40.1 % (637)
Triple-lumen 61.2 % (85) 54.1 % (815) 70.7 % (41) 54.1 % (859)
Total parenteral nutrition \0.001 \0.001
Yes 82.0 % (114) 60.6 % (904) 91.4 % (53) 60.8 % (965)
No 18.0 % (25) 40.0 % (603) 8.6 % (5) 39.2 % (623)
Transfusion 0.830 0.657
Yes 74.1 % (103) 73.3 % (1,104) 75.9 % (44) 73.2 % (1,163)
No 25.9 % (36) 26.7 % (403) 24.1 % (14) 26.8 % (425)
Data are presented as median (range) or % (n)
CRLI catheter-related local infection, CRBSI catheter-related bloodstream infection, ICU intensive care unit
a Catheter types are classified according to the number of catheter lumens
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1.002–1.046, P = 0.032) was significantly associated with
CRBSI in the multivariate analysis (Table 7).
Discussion
Previous studies that have analyzed CRLI in multidisci-
plinary ICUs have reported incidences of 6–15 % and
infection rates of 1.47–6.05 per 1000 days [1, 7]. In the
present study, we observed similar, although slightly
higher, incidences and infection rates (7.07 % and 5.75 per
1000 days, respectively). However, only a few previous
studies have evaluated CRLI, using various clinical diag-
nostic criteria, and more organized prospective studies are
needed to provide a more accurate estimation of the inci-
dence and infection rate.
In contrast, numerous studies have evaluated CRBSI,
with reported incidences varying from 1 to 13 % [1, 7–19].
According to the National Nosocomial Infections Surveil-
lance (NNIS) report in 2004, the CRBSI rate from various
ICUs was 1.8–5.2 per 1000 days [20], and the highest rate
was observed in a trauma ICU. Happily, another study has
reported that the CRBSI rate decreased each year between
2005 and 2010 [21], and additional studies have reported
decreases to 2.05 per 1000 days (in a 2009 study) and 0.4
per 1000 days (in a study of 21,259 catheter days) [22, 23].
These decreasing CRBSI rates are thought to be related to
the strict use of full barrier protection, antibiotic-coated
catheters, ultrasonography, and thorough catheter man-
agement [24, 25]. Although the present study only evalu-
ated severe trauma patients, while the previous studies have
evaluated multidisciplinary ICUs and trauma ICUs using
the NNIS guidelines, we observed a slightly lower CRBSI
rate of 2.4 per 1000 days. This difference may be related to
our strict institutional adherence to the NNIS guidelines,
which we believe has reduced our CRBSI rate.
There is currently debate regarding the optimal CVC
insertion site for lowering the CRBSI rate, and various
guidelines have been released, based on previous studies.
However, few studies have evaluated this topic for CRLI,
although a study by Lorente et al. revealed that the highest
CRLI rate occurred in the femoral vein, while the lowest
rate occurred in the subclavian vein [1]. Regarding the
CRBSI rate, several studies have found that the femoral
access has the highest rate [1, 7, 13, 26, 27], while other
studies have found that the internal jugular access has the
highest rate [17, 18, 28]. However, the internal jugular
access and subclavian access have been compared in other
studies, and those studies have reported that the jugular
access has a higher CRBSI rate compared to the subclavian
access [9, 14, 29]. Furthermore, the CDC guidelines have
recommended the optimal access site order (subclavian,
internal jugular, and femoral vein, respectively) in ‘‘rec-
ommendation 1A,’’ which is based on data from several
large studies. However, Marik et al. have stated that rec-
ommendation 1A may not be supported by the results of
various studies; therefore, even the current guidelines
cannot be considered a consensus opinion [21, 24, 30].
Moreover, those studies evaluated patients who were in
critical condition at multidisciplinary ICUs (not necessarily
for trauma-related reasons), and their results may not be
relevant to the trauma setting, where the patient’s condition
may limit access site availability and increase the risk of
infection via contaminated wounds.
Table 6 Multivariate analysis of the confounding variables that were associated with central catheter-related local infection
Model Covariates OR (95 % CI) P value
1 ICU length of stay (days) 1.004 (0.999–1.008) 0.135
Catheter insertion duration (days) 1.032 (1.017–1.047) \0.001
Catheter insertion site—subclavian 0.549 (0.376–0.801) 0.002
2 Catheter insertion duration (days) 1.035 (1.021–1.050) \0.001
Catheter insertion site—subclavian 0.532 (0.366–0.775) 0.001
OR odds ratio, CI confidence interval, ICU intensive care unit
Table 7 Multivariate analysis of the confounding variables that were associated with central catheter-related bloodstream infection
Model Covariates OR (95 % CI) P value
1 ICU length of stay (days) 1.003 (0.996–1.010) 0.423
Catheter insertion duration (days) 1.021 (0.998–1.045) 0.075
Number of catheter lumens 1.738 (1.019–2.963) 0.042
2 Catheter insertion duration (days) 1.024 (1.002–1.046) 0.032
Number of catheter lumens 1.696 (0.998–2.883) 0.051
OR odds ratio, CI confidence interval, ICU intensive care unit
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Our results indicate that only the use of the subclavian
vein significantly affected the CRLI rate, although no
significant differences were observed in the CRBSI rates
when we compared the three sites. However, the inguinal
area has a high density of local skin flora, which can likely
increase that site’s infection rate, although we have
markedly reduced the chances of infection at the femoral
access by implementing the procedural suggestions from
previous studies. When femoral access was unavoidable,
we transferred the catheter to the other sites as soon as
possible to decrease the catheter insertion duration and
infection rate. Based on that process, the femoral vein
appears to have a superior CRBSI rate, although this dif-
ference was not statistically significant. This finding may
be related to the fact that we removed the femoral catheter
as soon as possible, as catheter insertion duration was
positively associated with both the CRLI and CRBSI rates.
Furthermore, the higher infection rate at the internal
jugular access (vs. the subclavian access) may be related to
an increased likelihood of contamination from the oral
cavity and tracheostomy sites (due to proximity), or to the
presence of skin creases around the jugular access, which
made it difficult to maintain an appropriate position for the
gauze dressing.
Regarding the microorganisms that were responsible for
CRBSI, our findings are similar to those of previous
studies, which have reported that gram-positive bacteria are
the most common, although we, and other investigators,
have observed that yeasts are more common than gram-
negative bacteria [20, 31]. In our center, third-generation
cephalosporin is typically used for the initial antibiotic
treatment for severe trauma patient, and the wide antibiotic
spectrum may be partially responsible for our findings.
Among hospital-acquired infections, the rate of fungemia
has increased over the past two decades, and several studies
have reported that this increase is related to the increased
use of broad-spectrum antibiotics [32]. Furthermore, once
yeast appears in the blood, which can adhere to the catheter
tip under the fibrous protein membrane, thereby escaping
the patient’s immune system and any anti-fungal agents,
and subsequently contribute to the CRBSI rate [33]. This
mechanism may explain the higher rate of yeast or mul-
tidrug-resistant microorganisms that were related to
CRBSI.
There are several limitations in our study. First, our
study used a retrospective design. Second, the insertion
sites were not randomly assigned and were selected based
on existing treatment guidelines. Third, we did not use the
CDC’s definition of CRBSI (‘‘differential period of CVC
culture versus peripheral blood culture positivity of more
than 2 h’’), as our blood and catheter tip culture system was
not designed for this comparison. Therefore, it is possible
that our findings are different from those of previous
studies that followed the CDC guidelines. Fourth, we only
assessed infectious complications, as complete data
regarding iatrogenic complications (e.g., pneumothorax,
arterial puncture, or thrombosis) were not available. Nev-
ertheless, the occurrence of these complications might
influence the selection of an appropriate catheter insertion
site.
Conclusions
Although selection of the CVC site was limited in severe
trauma patients, our results suggest that catheter insertion
through the subclavian vein may reduce the CVC-related
infection rate in severe trauma patients, compared to
insertion through the internal jugular or femoral veins. In
addition, catheter insertion duration is significantly asso-
ciated with the rate of central catheter-related infection.
Therefore, this study confirms that the subclavian vein
should be selected first, followed by the internal jugular
vein, and the femoral vein as the last option. Although
severe trauma may necessitate the use of the femoral vein,
we suggest moving catheters from the femoral vein to the
subclavian vein as quickly as possible; the internal jugular
vein might also be needed in these cases. Furthermore, we
recommend that the CVC be completely removed as soon
as it is no longer indicated. However, further prospective
studies are needed to confirm these findings and
recommendations.
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